The European Paediatric Mycology Network (EPMyN) was launched in 2014 to create a European platform for research and education in the field of Paediatric Mycology. Its aim is to increase the knowledge of the epidemiology and pathogenesis and to improve the management of invasive fungal infections in neonates and children.

The objectives of the EPMyN are:

  • to investigate the clinical epidemiology of invasive fungal infections in neonates and children
  • to create a forum for educating and training colleagues in the field of paediatric mycology
  • to investigate new diagnostic and treatment modalities of fungal infections in specific paediatric groups

Led by EpMyn, the EURO-CANDY study focussed on collecting the necessary information about the current management of invasive fungal infections in children and neonates from a large number of European centres.
In January 2020 the new CALYPSO study launched. CALYPSO is a multicentre prospective modified point prevalence study, the results of which will be used in order to design an optimal paediatric antifungal stewardship programme.

Our first post-graduate course in Paediatric Mycology took place on October 12-13, 2015 in Lisbon, Portugal. This post-graduate course specifically targets paediatric infectious diseases specialists, paediatric hemato-oncologists and immunologists, paediatric pulmonologists and neonatologists (and those in training).

Steering group: Adilia Warris (chair), Andreas Groll, Andrew Cant, Carlo Giaquinto, Elio Castagnola, Emmanuel Roilides, Irja Lutsar, Mike Sharland, Nigel Klein, Paolo Manzoni, Roger Brüggemann, Thomas Lehrnbecher.

Contact: Prof. dr. Adilia Warris, MRC Centre for Medical Mycology, University of Exeter. E-mail: a.warris@exeter.ac.uk

This network is funded by Penta.